IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...

CLIMATE change is one of the most pressing crises of our time, with far-reaching consequences for lives, livelihoods, and ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform. The deal will see AstraZeneca scoop up all ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...

An advocacy group for survivors of clergy sexual abuse is demanding action from the Catholic Diocese of Peoria Bishop Louis ...

When Cassius Lockett was getting his undergraduate degree at the University of California, Davis, he worked in the kitchen of ...

Aetha, Inc., a pioneering applied AI company, today announced the official public launch of Zeno, a revolutionary Personal Growth Operating System now exiting beta and available completely free of ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

About the Role You will support the Cancer services Clinical Trial and Investigational Medicines used at St Vincent’s Hospital Melbourne including dispensing, drug accountability and preparation. The ...